Moderna shares soar on melanoma drug trial success
Go back to Moderna shares soar on melanoma drug trial success| Merck & Co. (NYSE: MRK) | Delayed: 150.33 -2.01 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.34 | 52 Week High | $65.46 | |||
| Open | $150.83 | 52 Week Low | $47.97 | |||
| Day High | $152.22 | P/E | 102.27 | |||
| Day Low | $150.09 | EPS | $1.47 | |||
| Volume | 4,395,788 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 145.55 -3.32 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.87 | 52 Week High | $0.52 | |||
| Open | $153.62 | 52 Week Low | $0.08 | |||
| Day High | $154.69 | P/E | N/A | |||
| Day Low | $141.52 | EPS | $-3.80 | |||
| Volume | 14,958,065 | |||||
